Our new design is here! Clearer, more modern, more international. With our new design and visual language we have achieved a strong visual alignment with the corporate identity of Revvity, Inc. At the same time, we harmonized the visual appearance of the Euroimmun and IDS brands creating a new modernized look which visually reflects our shared identity and growing collaboration. But what really counts remains the same: our […]
Vector-borne diseases such as dengue, chikungunya, Zika and West Nile fever account for more than 17% of all infectious diseases worldwide [1]. According to the World Health Organization (WHO), over 5.6 billion people live in areas at risk of arboviral infections – that’s more than half of the global population [2]. With over 35 years
Anyone who has got a pet rat at home knows how intelligent and adaptable these animals are. And they are becoming increasingly popular as pets. However, as with all animals in human care, there is a risk of them transmitting pathogens, such as hantaviruses, to humans. Hantaviruses, which occur worldwide, belong to the group of
The integration of Immunodiagnostic Systems (IDS) products into the Euroimmun portfolio has created a unique and broad menu of speciality testing solutions. Our combined chemiluminescence immunoassay (ChLIA) range now spans more than 200 analytes from six diagnostic areas: endocrinology, autoimmunity, infectious diseases, allergy, Alzheimer’s disease and therapeutic drug monitoring. ChLIAs from multiple diagnostic areas can
This milestone is much more than just a number: Every single installation stands for a laboratory that decided to leave manual processes behind and to opt for a solution that combines efficiency, safety, scalability and automation aspects. Today, the laboratory management system EUROLabOffice and its successor EUROLabOffice 4.0 are installed in more than 60 countries
